Search citation statements

Order By: Relevance
Select...
1
0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

0
1
0
Order By: Relevance
“… 98 Emapalumab Human IgG1 - IFN-γ - Phase 2/3 (NCT04324021) 99 Leronlimab (PRO 140) Humanized IgG4κ Mouse CCR5 - Phase 2/3 (NCT04343651, etc.) 100 Complement Ravulizumab Humanized IgG2 Mus musculus C5 - Phase 3/4 (NCT04570397, etc.) 101 Eculizumab Humanized IgG2/4κ Mouse C5 - Phase 2/3 (NCT04288713, etc.)…”
Section: Sars-cov-2 and Conventional Igg Mabsmentioning
Create an account to read the remaining citation statements from this report. You will also get access to:
  • Search over 1.2b+ citation statments to see what is being said about any topic in the research literature
  • Advanced Search to find publications that support or contrast your research
  • Citation reports and visualizations to easily see what publications are saying about each other
  • Browser extension to see Smart Citations wherever you read research
  • Dashboards to evaluate and keep track of groups of publications
  • Alerts to stay on top of citations as they happen
  • Automated reference checks to make sure you are citing reliable research in your manuscripts
  • 14 day free preview of our premium features.

Trusted by researchers and organizations around the world

Over 130,000 students researchers, and industry experts at use scite

See what students are saying

rupbmjkragerfmgwileyiopcupepmcmbcthiemesagefrontiersapsiucrarxivemeralduhksmucshluniversity-of-gavle
“… 98 Emapalumab Human IgG1 - IFN-γ - Phase 2/3 (NCT04324021) 99 Leronlimab (PRO 140) Humanized IgG4κ Mouse CCR5 - Phase 2/3 (NCT04343651, etc.) 100 Complement Ravulizumab Humanized IgG2 Mus musculus C5 - Phase 3/4 (NCT04570397, etc.) 101 Eculizumab Humanized IgG2/4κ Mouse C5 - Phase 2/3 (NCT04288713, etc.)…”
Section: Sars-cov-2 and Conventional Igg Mabsmentioning